Identify how type 2 inflammation contributes to the pathology of chronic rhinosinusitis with nasal polyps (CRSwNP)

Evaluate the latest data on the efficacy, safety, dosing, and administration of novel TYK2 inhibitors for patients with psoriasis.

Evaluate the mechanism of action, safety, and efficacy of biologics for the treatment of chronic rhinosinusitis with nasal polyps

Asthma is one of the most common chronic conditions in the pediatric population, and although existing medications can reduce symptoms, management is still suboptimal. The availability of novel biologic therapies for the treatment of asthma requires clinicians to better understand when and in which patients to consider them.